1Saxe A. Parathyroid transplantation:a review[J].Surgery, 1984,95(5) :507-526.
2Wingender E, Bercz G, Blocker H, et al. Expression of human parathyroid hormone in Escherichia Coli [ J ]. J Bio Chem, 1989,264 ( 8 ): 4367-4373.
3Schachter P, Christy MD, Leight GS, et al. Function in athymic nude mice of parathyroid heterografts from patients with primary hyperparathyroidism and secendry hyperparathyroidism [ J ]. Surgery, 1990, 108(6): 1040-1046.
5Kadowaki MH, Fulton N, Schark C, et al. Difficalties of parathyroidectomy after previous thyroidectomy[ J]. Surgery, 1989, 106(6): 1018-1023.
6Starling JR, Fidler R, Corry RJ. Prolongation of survival of rat parathyroid allografts by enhancing serum and tissue culture[J].Surgery,1977,81(6):668-675.
7Blaese RM, Culver KW, Miller AD, et al. T lumphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years[J]. Science,1995,270 (5235) :475-480.
8Verdier F, Descotes J. Preclinical safety evaluation of human gene therapy products[ J]. Toxical Sci, 1999,47( 1 ) :9-15.
8[1]Dai Y, Roman M, Naviaux RK, et al. Gene therapy via primary myoblasts :long term expression of factor Ⅸ protein following transplantation in vivo[J]. Proc Natl Acad Sci USA,1992, 89: 10892-10895.
9[2]Naldini L, Blome V, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector[J]. Science, 1996, 272: 263-267.
10[3]Blaese RM ,Culver KW, Miller AD, et al. T-lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years[J]. Science, 1995,270:475-480.
8Schachter P,Christy MD,Leight GS,et al.Function in athymic nude mice of parathyroid heterografts from patients with primary hyperparathyroidism and secondary hyperparathyroidism[J].Surgery,1990,108(6):1040-1046.
9Kadowaki MH,Fulton N,Schark C,et al.Difficulties of parath-yroidectomy after previous thyroidectomy[J].Surgery,1989,106(6):1018-1024.
10Tsuji K,Fuchinoue S,Kai K,et al.Culture of human parathyroidcells for transplantation[J].Transplant Proc,1999,31(7):2697.
